Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Crunchfish is official Offline Payments Partner at the Global Fintech Fest in India

Crunchfish will next week attend the Global Fintech Fest in Mumbai, the largest fintech event in India, as official Offline Payments Partner. The patented Digital Cash solution will be showcased at the exhibition and Crunchfish’s CEO Joachim Samuelsson will host a panel discussion on “The impact of offline payments in a digital world: Robustness, Privacy and Inclusion”. Crunchfish is the official Offline Payments Partner to the Global Fintech Fest 2023  (GFF) in Mumbai, India. GFF is held September 5-7 and is the largest fintech conference in India,

DanCann Pharma A/S to refocus its strategy - will reinvigorate its pipeline and product portfolio, and start looking for future owner or partnership for BP1

COPENHAGEN, Denmark, 31 August 2023 – DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby inform the market of a significant change in its strategic business focus, effective immediately. This shift reflects the commitment to adapt to evolving market dynamics and position DanCann Pharma for sustainable growth.The new strategic direction will build upon the existing strengths, notably CannGros. Going forward, the Company will significantly increase its emphasis on sourcing, distribution, and sales within the

Episurf Medical: Approaching 510(k) submission for big toe implant

Episurf Medical (NASDAQ: EPIS B) today provides an update on the planned 510(k) filing to the US FDA for the company’s implant for the 1[st] MTP joint of the big toe. The company plans to file the 510(k) submission for US market clearance during the coming weeks. The company aims to receive clearance to be able to launch the product on the US market during 2024. The company is currently assessing various options for commercialization strategy, including independent distributors and technology licensing. The implant is intended to treat osteoarthritis (hallux rigidus) in the big toe. It

Viaplay and CH Media add oneplus to Viaplay Select’s DACH footprint

· Viaplay Select to be present in all DACH countries from September · Viaplay Select adds over 900 hours of premium content to CH Media’s streamer oneplus, with further licensing across CH Media’s full portfolio of channels and services · Viaplay Select deals now announced for 22 territories worldwide Viaplay Group and Switzerland’s CH Media have agreed a multi-year partnership that secures more than 900 hours of Viaplay Select’s curated premium content for CH Media’s oneplus streaming service. The deal is the first in Switzerland for Viaplay Select, a branded content concept for

Valmet to supply key pulp and paper technologies to Naini Papers in India

Valmet Oyj’s press release on August 31, 2023 at 9:30 a.m. EESTValmet will deliver key technologies, automation and services to Naini Papers’ cooking and fiberline rebuild and new specialty paper machine PM 3 at their mill in Kashipur, India. The delivery will increase the mill’s capacity and support meeting the market demand of specialty coated paper. The delivery is scheduled for the first quarter 2025.  The order was included in Valmet’s orders received of the second quarter 2023. The value of the order will not be disclosed, but a delivery of this size and scope is typically valued

Scandic to expand Signature Collection in Norway and Denmark

The hotels are already part of Scandic’s pipeline and will open in 2025 in Tromsø, Norway, and in 2026 in Aarhus, Denmark. The two hotels will now be part of the company’s Signature Collection that aims to meet the demand from the growing leisure segment. Today, Scandic has five signature hotels in Stockholm, Helsinki, Bergen and Oslo that target global travelers who consider the hotel stay to be the destination, regardless of the purpose of a trip.Scandic’s Signature Collection is a range of lifestyle hotels that have been developed to bring out a hotel’s individual character and satisfy

Interim Report January - June 2023

April 1st – Jun 30th 2023 · Net sales amounted to EUR 3 912 thousand (6 763) · EBITDA of 432 thousand (301) and EBITDA margin of 11% (4.4) · EBIT of EUR 392 thousand (194) and EBIT margin of 10 % (2.9) · Net earnings after tax of EUR 158 thousand (106) and net EAT margin of 4.0% (1.6)  Jan 1st – Jun 30th 2023 · Net sales amounted to EUR 7 584 thousand (12 899) · EBITDA of EUR 594 thousand (365) and EBITDA margin of 7.8% (2.8) · EBIT of EUR 520 thousand (157) and EBIT margin of 7% (1.2) · Net earnings after tax of EUR 405 thousand (-170) and net EAT margin

Summary of H1 2023 report: Brain+ has closed new sales contracts, built key customer engagement, developed a new product concept, achieved technology validations and secured new funding

Brain+ A/S (BRAINP) - Company Announcement Thursday, August 31, 2022, 8:30 CETToday, Brain+ has released its financial report for the period 1 January - 30 June 2023 (unaudited) including a business update for the year to date.Business highlights: · We have expanded our first sales contract with the municipality of Herning and closed our second contract with a dementia care institution in Gladsaxe municipality, both giving CST therapists access to use our Danish CST-Therapist Companion v1.0 to support the delivery of Cognitive Stimulation Therapy (CST) group therapy to people with

Conversion of shares

According to Essity’s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in the company. When such a conversion has occurred, the company is obligated by law to disclose any such changes in this manner.In August, at the request of shareholders, 75 Class A shares were converted to Class B shares. The total number of votes in the company thereafter amounts to 1,252,772,040. The total number of registered shares in the company amounts to 702,342,489 of which 61,158,839 are Class A

Integrum reports highest quarterly sales revenue ever

FIRST QUARTER 2023/24 (MAY – JULY) · Net sales amounted to SEK 20.4 (17.2) million, which is an increase of 18% compared with the corresponding period last year. · Operating profit amounted to SEK -2.9 (0.4) million. Excluding one-off costs the operating profit is SEK 0.5 million. The largest such cost is severance pay regarding the change of leadership in the US. · Profit/loss after tax amounted to SEK -2.9 (-0.6) million, which resulted in earnings per share of SEK -0.1 (-0.03). · Cash flow from operating activities before changes in working capital amounted to SEK -2.6 (-0.3)

Greenfood's climate targets receive SBTi approval

The Science Based Targets initiative (SBTi) has approved the targets Greenfood set to limit global warming to 1.5°C in line with the Paris Agreement. Greenfood commits to reducing emissions from its operations (Scope 1 & 2) by 42% by 2030, with a base year of 2021, and reducing emissions in its value chain (Scope 3) by 52% by 2030, also using 2021 as the base year.Greenfood has taken a significant step forward in its sustainability journey by receiving approval for its climate goals from the Science Based Targets initiative (SBTi). The SBTi serves as a global standard, guiding companies to

SKF appoints Sophie Arnius as Head of Investor Relations

Gothenburg, 31 August 2023: Sophie Arnius has been appointed Head of Investor Relations, starting latest 24 February 2024. Sophie joins SKF from Electrolux and she succeeds Patrik Stenberg who will continue in his role as Director, Mergers & Acquisitions. Sophie Arnius has extensive experience from working towards the financial markets and with other relevant stakeholders. She is currently Head of Investor Relations at Electrolux, and she has previously held similar positions at Boliden and BillerudKorsnäs. Sophie will report to Niclas Rosenlew, Chief Financial Officer at SKF.

United Bankers Plc: Notification of Manager’s Transactions – Paadla AS

United Bankers Plc STOCK EXCHANGE RELEASE 31 August 2023 at 9:00 EEST   United Bankers Plc: Notification of Manager’s Transactions – Paadla AS ____________________________________________ Person subject to the notification requirement Name: Paadla AS Position: Closely associated person (X) Legal person (1): Person Discharging Managerial Responsibilities In Issuer Name: Patrick Anderson Position: Chief Executive Officer Issuer: United Bankers Plc LEI: 743700J2WO3J6XGFPG77 Notification type: INITIAL NOTIFICATION Reference number: 37214/4/4 _________

Lytix Biopharma presents first half and second quarter 2023 results

Building a Phase II evidence base Oslo, 31 August 2023. Lytix Biopharma – Lytix Biopharma AS (“Lytix”) (Euronext Growth Oslo: LYTIX), a clinical stage immuno-oncology company, today releases its first half and second quarter 2023 results.Chief Executive Officer of Lytix Biopharma, Dr. Øystein Rekdal, commented: “We have continued to make positive progress as we build a clinical Phase II evidence base for our lead compound LTX-315. Earlier this month we received strong data from Part 1 of Verrica Pharmaceuticals’ ongoing clinical Phase II study and more recently we announced the

Norse Atlantic Airways Q2 2023 report -Strong growth in revenue and strong momentum going into Q3

• Revenue increased by 152% quarter-on-quarter (“QoQ”) to USD 100.1 million • 204,564 passengers carried, up 86% QoQ • Revenue per passenger increased 89% QoQ to USD 422 • Available Seat Kilometres (ASK) up by 51% QoQ due to planned ramp-up as Norse brought more aircraft into production • Positive EBITDAR of USD 2.2 million, the first positive EBITDAR on a quarterly basis since inception of the Company • Intra-quarter Norse recorded its first profitable month (June) and continued positive momentum into Q3 • Load factors showed strong development during the quarter, with

MSAB appoints new CEO

The board of MSAB (Micro Systemation AB publ), a world-leading company in mobile forensics, has appointed Peter Heuman as the new CEO of MSAB, starting on October 1, 2023. Heuman replaces Mikael Falkovén, acting CEO since March 2023."Heuman has a solid international background with a clear business focus and is a valued leader who shares MSAB's values. I am convinced that we have found a competent CEO who can further develop MSAB. I would also like to thank Mikael Falkovén for his good work during the time that the recruitment of the new CEO has been going on. MSAB is stable, ready to

ZINZINO AB (PUBL): INTERIM REPORT SECOND QUARTER 2023

ZINZINO ADJUSTS THE FULL-YEAR FORECAST AFTER ANOTHER VERY STRONG QUARTER The total revenues during the second quarter of 2023 amounted to SEK 407.9 (329.5) million, which corresponded to 24% (2%) growth compared to the corresponding quarter of the previous year. The EBITDA result increased to SEK 53.7 (20.1) million for the quarter and the EBITDA margin increased to 13.2% (6.1%). The margin improvement was mainly achieved through changes in the sales mix, efficiencies and economies of scale. The good profitability during the first half of the year means that the board is now writing up

RightBridge Ventures Group AB interim Q2 2023 report

STRONG REVENUE and GROSS MARGIN GROWTH DURING THE FIRST 6 MONTHS OF THE YEAR EBITDA IMPACTED BY EXTRAORDINARY EXTERNAL EXPENSES as well as TRICKED ApSProfit and loss, in summary, Apr-Jun Jan-June Jan-Dec groupSEK thousands 2023 2022 2023 2022   2022   Revenue 1.621 1.916 4.151 2.564   8.445EBITDA -3.328 -2.569 -8.795 -3.751 -23.598Adjusted EBITDA -2.899 -2.569 -5.421 -3.751 -12.219Depreciation, amortization -781 -226

New study: Capitainer’s technology enables finger-prick self-sampling at home for kidney transplant patients

A new study performed at Oslo University Hospital has validated the usability of Capitainer's pioneering self-sampling device for the standard panel of biomarkers used for monitoring kidney transplanted patients. Capitainer maintained consistent sampling success and analytical quality, generating reliable results regardless of whether the microsampling was performed by healthcare personnel or the patient.Medical technology company Capitainer’s patented sampling products are based on patients taking blood samples, themselves or with assistance, using a unique technology for collecting an

Spinnova Plc's Half-Year Report January-June 2023 (unaudited): The technology handover to Woodspin was conducted successfully - Revenues increased and operating result decreased, as expected

SPINNOVA PLC, COMPANY RELEASE, 31 AUGUST 2023, 08:45 A.M. EEST This release is a summary of Spinnova’s half-year report January to June 2023. The complete report is attached to this release and available on the company’s website at https://spinnovagroup.com/reports/. Spinnova Plc’s Half-Year Report January–June 2023 (unaudited) The technology handover to Woodspin was conducted successfully - Revenues increased and operating result decreased, as expectedJanuary to June 2023 highlights (IFRS)(comparison figures in parentheses are for January-June 2022 if nothing else is

Inside information: Spinnova to review its strategy and medium- and long-term business targets

Spinnova PLC, Company Release, INSIDE INFORMATION, 31 August 2023 at 8.35 a.m. EEST   Inside information: Spinnova to review its strategy and medium- and long-term business targets   The demand drivers and opportunity for Spinnova continue to be very strong and the company’s ambition level to transform the global textile industry is unchanged. Spinnova has decided to evaluate its existing strategy to prioritise areas in the strategy that in the short- to medium-term deliver the fastest time to positive cashflow generation and that create the most value for the company’s

ABAX exceeds growth expectations in Quarter 2 (Q2)

31.08.2023, Larvik, Norway | ABAX Group announces its Q2 2023 results. The Q2 report is available on the company website at: https://www.abax.com Highlights Q2: · Operational Revenue  of 203,2 (182,7) MNOK, 11% growth year-over-year · Revenue growth across all key geographical market segments. · Adjusted EBITDA of 92,3 (84,7) MNOK, 9% growth year-over-year · Annualized Recurring Revenue (ARR) at 788,5 MNOK, up 7% year-over-year. · Signed new and improved contract with connected insurance partner Zego. · Employee engagement survey score at 83%,

Read original
There are no items matching the current filter
There are no more items matching the current filter
Back to top